The KAAACI Standardization Committee Report on the procedure and application of fractional exhaled nitric oxide measurement
Allergy, Asthma & Respiratory Disease
;
: 185-192, 2017.
Article
in Korean
| WPRIM
| ID: wpr-145713
ABSTRACT
Fractional exhaled nitric oxide (FeNO) is a biomarker for type 2 inflammation in the airways, and its measurement has the distinct strengths of being simple, rapid, convenient, and reproducible. Since the discovery of FeNO in the 1990s, its measurement tools have been extensively developed and validated by several researchers. In particular, FeNO showed the potential to support the diagnosis of asthma and eosinophilic bronchitis. Since it has begun to be widely utilized in clinical research areas as well as daily practice, we summarized the standardized diagnostic procedures and suggested the clinical application of FeNO measurement in Korean population.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Asthma
/
Bronchitis
/
Diagnostic Techniques and Procedures
/
Diagnosis
/
Eosinophils
/
Inflammation
/
Nitric Oxide
Type of study:
Diagnostic study
Language:
Korean
Journal:
Allergy, Asthma & Respiratory Disease
Year:
2017
Type:
Article
Similar
MEDLINE
...
LILACS
LIS